TSX closed
Loading markets…

Advertisement

Stocks

Why Profound Medical Corp stock surged yesterday

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:PRN.TO

Follow PRN

Photos provided by Pexels

Profound Medical Corp saw a remarkable rise in its stock price, reflecting strong market interest in its innovative healthcare solutions.

Profound Medical Corp (PRN.TO) experienced a significant surge in its stock price yesterday, closing up by 20.59% at CA$9.84. This impressive performance highlights the growing investor confidence in the company's AI-driven medical technologies.

Advertisement

Profound Medical Corp

PRN.TO

Full stock page →

PRN.TO

Profound Medical Corp

Source:WealthAwesomeWealthAwesome
↓ $0.02 (-0.20%)
120 day period
$7.92$9.84$11.76Apr 20Jul 15Oct 8

Market cap

$359.48M

52W high

$12.40

52W low

$6.52

1W change

+17.84%

Beta

0.56

Analyst Price Targets

Based on analyst covering PRN · as of Sep 17, 2026

📈

Wall Street analysts forecast PRN stock price to rise 154.4% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$25.03

+154.4% Upside

Current Price

C$9.84

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on PRN's historical volatility

HistoricalForecast68%95%
C$3.73C$7.96C$12.18C$16.40C$20.63C$24.85TodayJun 2Aug 6Oct 8Nov 20Jan 3Feb 15

30-Day Vol

76.8%

Annualized

90-Day Vol

61.7%

Annualized

Trend (90d)

-5.9%

Annualized drift

90d Mean

C$9.63

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$9.77C$7.50 – C$12.74
60 trading daysC$9.70C$6.67 – C$14.11
90 trading daysC$9.63C$6.09 – C$15.25

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors are increasingly optimistic about Profound Medical's role in the AI healthcare sector, particularly with its TULSA-PRO system that combines robotics and imaging for precise medical procedures.

20.59% Surge in Stock Price

Profound Medical's market cap now stands at CA$359.48 million, reflecting heightened investor interest in its innovative healthcare solutions.

Bull case

The growing interest in AI healthcare solutions positions Profound Medical for future growth. Hospitals are looking to adopt advanced technologies that improve patient outcomes and operational efficiency, making Profound's offerings particularly relevant.

Bear case

Despite the positive momentum, challenges remain. The pace of technology adoption in healthcare can be slow, and Profound Medical is currently not profitable. With a profit margin of -1.7156%, the company will need to address these issues to keep investors engaged.

Market Confidence in AI Healthcare

Advertisement

The surge in Profound Medical's stock price reflects increasing market confidence in AI healthcare technologies. As hospitals aim to boost their operational efficiency and patient care, innovations like the TULSA-PRO system are becoming more appealing. This system uses robotic control and real-time imaging to treat diseased tissue without incisions, making it an attractive option for healthcare providers.

Challenges Ahead

While the recent stock performance is promising, investors should stay cautious. The adoption of new technologies in healthcare can be slow, and Profound Medical has yet to achieve profitability. The company will need to navigate these challenges effectively to maintain investor interest.

Future Outlook

Looking ahead, the outlook for Profound Medical is optimistic, especially as demand for AI-driven healthcare solutions continues to rise. Investors should keep an eye on the company's progress in expanding its market presence and the adoption of its technologies in clinical settings. For more insights on Profound Medical, visit our stock page.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 9, 2026
Last Updated: October 9, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement